XYNOS KONSTANTINOS (Chief Medical Officer) received a stock award from REPLIMUNE GROUP, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/19/2025ACC: 0001104659-25-123286
Officer· Chief Medical Officer
Since Dec 2022
+60K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
60K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+60K
Price / share
—
Trade value
—
% of position
43.0%
12/19/2025
139.69K→199.69K
Total
Net shares
+60K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/19/2025 | A · Award | +60K | — | — | 43.0% | 139.69K | 199.69K |
| Total | +60K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported